Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

3F-NEB

From Wikipedia, the free encyclopedia

3F-NEB
Legal status
Legal status
Identifiers
  • 2-(ethylamino)-1-(3-fluorophenyl)butan-1-one
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H16FNO
Molar mass209.264 g·mol−1
3D model (JSmol)
  • CCC(C(=O)C1=CC(=CC=C1)F)NCC
  • InChI=1S/C12H16FNO/c1-3-11(14-4-2)12(15)9-6-5-7-10(13)8-9/h5-8,11,14H,3-4H2,1-2H3
  • Key:FLFAFGGBRUXYBD-UHFFFAOYSA-N

3-Fluoro-N-ethylbuphedrone (3F-NEB) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug.[1] It was first identified in Sweden in 2021.[2][3]

See also

[edit]

References

[edit]
  1. Pain S, Nadal-Gratacós N, De Macedo M, Lardeux V, Mata S, Puigseslloses P, et al. (February 2026). "Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone". European Journal of Pharmacology. 1015 178570. doi:10.1016/j.ejphar.2026.178570. hdl:20.500.14342/5980. PMID 41554370.
  2. European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/396103. ISBN 978-92-9497-737-3.
  3. Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.